The DOI matches its Crossref record; 124 of the 124 references it cites were found in a registry or an index.
AMPK As a Metabolic Tumor Suppressor: Control of Metabolism and Cell Growth
Open accessAbstract
AMPK is an evolutionarily conserved fuel-sensing enzyme that is activated in shortage of energy and suppressed in its surfeit. AMPK activation stimulates fatty acid oxidation, enhances insulin sensitivity, alleviates hyperglycemia and hyperlipidemia, and inhibits proinflammatory changes. Thus, AMPK is a well-received therapeutic target for metabolic syndrome and Type 2 diabetes. Recent studies indicate that AMPK plays a role in linking metabolic syndrome and cancer. AMPK is an essential mediator of the tumor suppressor LKB1 and could be suppressed in cancer cells containing loss-of-function mutations of LKB1 or containing active mutations of B-Raf, or in cancers associated with metabolic syndrome. The activation of AMPK reprograms cellular metabolism and enforces metabolic checkpoints by acting on mTORC1, p53, fatty acid synthase and other molecules for regulating cell growth and metabolism. In keeping with in vitro studies, recent epidemiological studies indicate that the incidence of cancer is reduced in Type 2 diabetes treated with metformin, an AMPK activator. Thus, AMPK is emerging as an interesting metabolic tumor suppressor and a promising target for cancer prevention and therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Kim, H. S., Hwang, J. T., Yun, H., Chi, S., Lee, S., Kang, I., Yoon, K., Choe, W.-J., Kim, S. S., & Ha, J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704432200 · Cited by 72
RetractedRepertoires of Autophagy in the Pathogenesis of Ocular Diseases
Li, Y.-J., Jiang, Q., Cao, G.-F., Yao, J., & Yan, B. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000373980 · Cited by 16,304
Mutations of the BRAF gene in human cancer
Davies, H., Bignell, G. R., Cox, C., Stephens, P., Edkins, S., Clegg, S., Teague, J., Woffendin, H., Garnett, M. J., Bottomley, W., et al. (2002) · Nature · doi:10.1038/nature00766 · Cited by 10,674
Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. Adults
Calle, E. E., Rodriguez, C., Walker-Thurmond, K., & Thun, M. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021423 · Cited by 7,696
Role of AMP-Activated Protein Kinase in Mechanism of Metformin Action
Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., Wu, M., Ventre, J., Doebber, T., Fujii, N., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13505 · Cited by 5,652
ras oncogenes in human cancer: a review.
Bos, J. L. (1989) · PubMed · Cited by 5,061
TSC2 Mediates Cellular Energy Response to Control Cell Growth and Survival
Inoki, K., Zhu, T., & Guan, K.-L. (2003) · Cell · doi:10.1016/s0092-8674(03)00929-2 · Cited by 3,914
AMPK Phosphorylation of Raptor Mediates a Metabolic Checkpoint
Gwinn, D. M., Shackelford, D. B., Egan, D. F., Mihaylova, M. M., Mery, A., Vasquez, D. S., Turk, B. E., & Shaw, R. J. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.03.003 · Cited by 3,849
On Respiratory Impairment in Cancer Cells
Warburg, O. (1956) · Science · doi:10.1126/science.124.3215.269 · Cited by 3,468
Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway.
Kaelin, W. G., & Ratcliffe, P. J. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.04.009 · Cited by 3,251
Defining the role of mTOR in cancer
Guertin, D. A., & Sabatini, D. M. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.05.008 · Cited by 2,833
Targeting PI3K signalling in cancer: opportunities, challenges and limitations
Engelman, J. A. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2664 · Cited by 2,445
Metformin and reduced risk of cancer in diabetic patients
Evans, J. M. M., Donnelly, L. A., Emslie-Smith, A. M., Alessi, D. R., & Morris, A. D. (2005) · BMJ · doi:10.1136/bmj.38415.708634.f7 · Cited by 2,388
Tumor cell metabolism: cancer's Achilles' heel
Kroemer, G., & Pouyssegur, J. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.05.005 · Cited by 2,337
AMP-activated/SNF1 protein kinases: conserved guardians of cellular energy
Hardie, D. G. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2249 · Cited by 2,216
Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase
Minokoshi, Y., Kim, Y.-B., Peroni, O. D., Fryer, L. G. D., Müller, C., Carling, D., & Kahn, B. B. (2002) · Nature · doi:10.1038/415339a · Cited by 2,053
The LKB1-AMPK pathway: metabolism and growth control in tumour suppression
Shackelford, D. B., & Shaw, R. J. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2676 · Cited by 1,943
Shaw, R. J., Kosmatka, M., Bardeesy, N., Hurley, R. L., Witters, L. A., DePinho, R. A., & Cantley, L. C. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308061100 · Cited by 1,797
Hawley, S. A., Boudeau, J., Reid, J. L., Mustard, K. J., Udd, L., Mäkelä, T. P., Alessi, D. R., & Hardie, D. G. (2003) · Journal of Biology · doi:10.1186/1475-4924-2-28 · Cited by 1,665
LKB1 is the upstream kinase in the AMP-activated protein kinase cascade
Woods, A., Johnstone, S. R., Dickerson, K., Leiper, F. C., Fryer, L. G. D., Neumann, D., Schlattner, U., Wallimann, T., Carlson, M., & Carling, D. (2003) · Current Biology · doi:10.1016/j.cub.2003.10.031 · Cited by 1,650
p53 Regulates Mitochondrial Respiration
Matoba, S., Kang, J.-G., Patino, W. D., Wragg, A., Boehm, M., Gavrilova, O., Hurley, P. J., Bunz, F., & Hwang, P. M. (2006) · Science · doi:10.1126/science.1126863 · Cited by 1,650
AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus
Minokoshi, Y., Alquier, T., Furukawa, N., Kim, Y.-B., Lee, A., Xue, B., Mu, J., Foufelle, F., Ferré, P., Birnbaum, M. J., et al. (2004) · Nature · doi:10.1038/nature02440 · Cited by 1,637
Steinberg, G. R., & Kemp, B. E. (2009) · Physiological Reviews · doi:10.1152/physrev.00011.2008 · Cited by 1,637
AMP-activated protein kinase induces a p53-dependent metabolic checkpoint
Jones, R. G., Plas, D. R., Kubek, S., Buzzai, M., Mu, J., Xu, Y., Birnbaum, M. J., & Thompson, C. B. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.03.027 · Cited by 1,619
Hawley, S. A., Pan, D. A., Mustard, K. J., Ross, L., Bain, J., Edelman, A. M., Frenguelli, B. G., & Hardie, D. G. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.05.009 · Cited by 1,589
Glycolysis inhibition for anticancer treatment
Pelicano, H., Martin, D. S., Xu, R.-H., & Huang, P. (2006) · Oncogene · doi:10.1038/sj.onc.1209597 · Cited by 1,516
SREBP activity is regulated by mTORC1 and contributes to Akt-dependent cell growth
Porstmann, T., Santos, C. R., Griffiths, B., Cully, M., Wu, M., Leevers, S., Griffiths, J. R., Chung, Y.-L., & Schulze, A. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.07.007 · Cited by 1,413
Woods, A., Dickerson, K., Heath, R., Hong, S.-P., Momcilovic, M., Johnstone, S. R., Carlson, M., & Carling, D. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.06.005 · Cited by 1,392
Inoki, K., Ouyang, H., Zhu, T., Lindvall, C., Wang, Y., Zhang, X., Yang, Q., Bennett, C., Harada, Y., Stankunas, K., et al. (2006) · Cell · doi:10.1016/j.cell.2006.06.055 · Cited by 1,377
p53 Target Genes Sestrin1 and Sestrin2 Connect Genotoxic Stress and mTOR Signaling
Budanov, A. V., & Karin, M. (2008) · Cell · doi:10.1016/j.cell.2008.06.028 · Cited by 1,326 · cited 1×
“A second study has revealed that two downstream targets of p53, sestrin 1 and sestrin 2, are implicated in the activation of AMPK and concordant inhibition of mTOR [52].”
BackgroundThe LKB1 tumor suppressor negatively regulates mTOR signaling
Shaw, R. J., Bardeesy, N., Manning, B. D., Lopez, L., Kosmatka, M., DePinho, R. A., & Cantley, L. C. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.06.007 · Cited by 1,077
LKB1 modulates lung cancer differentiation and metastasis
Ji, H., Ramsey, M. R., Hayes, D. N., Fan, C., McNamara, K., Kozlowski, P., Torrice, C., Wu, M. C., Shimamura, T., Perera, S. A., et al. (2007) · Nature · doi:10.1038/nature06030 · Cited by 1,064
AMPK: An Emerging Drug Target for Diabetes and the Metabolic Syndrome
Zhang, B. B., Zhou, G., & Li, C. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2009.03.012 · Cited by 1,026
New Users of Metformin Are at Low Risk of Incident Cancer
Libby, G., Donnelly, L. A., Donnan, P. T., Alessi, D. R., Morris, A. D., & Evans, J. M. M. (2009) · Diabetes Care · doi:10.2337/dc08-2175 · Cited by 996
Dowling, R. J. O., Zakikhani, M., Fantus, I. G., Pollak, M., & Sonenberg, N. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-2310 · Cited by 933
Buzzai, M., Jones, R. G., Amaravadi, R. K., Lum, J. J., DeBerardinis, R. J., Zhao, F., Viollet, B., & Thompson, C. B. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4447 · Cited by 923
Jiralerspong, S., Palla, S. L., Giordano, S. H., Meric-Bernstam, F., Liedtke, C., Barnett, C. M., Hsu, L., Hung, M.-C., Hortobagyi, G. N., & Gonzalez-Angulo, A. M. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.19.6410 · Cited by 880 · cited 1×
“Interestingly, one clinical study assessed the response of breast cancer patients with diabetes to nonadjuvant chemotherapy in combination with metformin or with nonmetformin anti diabetic drugs and demonstrated that the patients receiving metformin showed complete pathological responses [119].”
BackgroundLiang, J., Shao, S. H., Xu, Z.-X., Hennessy, B., Ding, Z., Larrea, M., Kondo, S., Dumont, D. J., Gutterman, J. U., Walker, C. L., et al. (2007) · Nature Cell Biology · doi:10.1038/ncb1537 · Cited by 866
Bolster, D. R., Crozier, S. J., Kimball, S. R., & Jefferson, L. S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.c200171200 · Cited by 851
Greer, E. L., Oskoui, P. R., Banko, M. R., Maniar, J. M., Gygi, M. P., Gygi, S. P., & Brunet, A. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m705325200 · Cited by 818
Fatty-acid synthase and human cancer: new perspectives on its role in tumor biology
Kuhajda, F. P. (2000) · Nutrition · doi:10.1016/s0899-9007(99)00266-x · Cited by 788
LKB1-Dependent Signaling Pathways
Alessi, D. R., Sakamoto, K., & Bayascas, J. R. (2006) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.75.103004.142702 · Cited by 788
Investigating the mechanism for AMP activation of the AMP-activated protein kinase cascade
Sanders, M. J., Grondin, P. O., Hegarty, B. D., Snowden, M. A., & Carling, D. (2007) · Biochemical Journal · doi:10.1042/bj20061520 · Cited by 666
Zang, M., Xu, S., Maitland-Toolan, K. A., Zuccollo, A., Hou, X., Jiang, B., Wierzbicki, M., Verbeuren, T. J., & Cohen, R. A. (2006) · Diabetes · doi:10.2337/db05-1188 · Cited by 664
Self-citationGlycolytic Enzymes Can Modulate Cellular Life Span
Kondoh, H., Lleonart, M. E., Gil, J., Wang, J., Degan, P., Peters, G., Martinez, D., Carnero, A., & Beach, D. (2005) · Cancer Research · doi:10.1158/0008-5472.177.65.1 · Cited by 647
Mitochondria in cancer cells: what is so special about them?
Gogvadze, V., Orrenius, S., & Zhivotovsky, B. (2008) · Trends in Cell Biology · doi:10.1016/j.tcb.2008.01.006 · Cited by 637
Feng, Z., Hu, W., de Stanchina, E., Teresky, A. K., Jin, S., Lowe, S., & Levine, A. J. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4149 · Cited by 633
Inactivation of LKB1/STK11 is a common event in adenocarcinomas of the lung.
Sánchez‐Céspedes, M., Parrella, P., Esteller, M., Nomoto, S., Trink, B., Engles, J. M., Westra, W. H., Herman, J. G., & Sidransky, D. (2002) · PubMed · Cited by 612
Activation of yeast Snf1 and mammalian AMP-activated protein kinase by upstream kinases
Hong, S.-P., Leiper, F. C., Woods, A., Carling, D., & Carlson, M. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1533136100 · Cited by 595
Shaw, R. J. (2006) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2006.10.005 · Cited by 550
AMPK and the biochemistry of exercise: implications for human health and disease
Richter, E. A., & Ruderman, N. B. (2009) · Biochemical Journal · doi:10.1042/bj20082055 · Cited by 481
Suter, M., Riek, U., Tuerk, R., Schlattner, U., Wallimann, T., & Neumann, D. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m606357200 · Cited by 477
Momcilovic, M., Hong, S.-P., & Carlson, M. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m604399200 · Cited by 473
Horman, S., Browne, G. J., Krause, U., Patel, J. V., Vertommen, D., Bertrand, L., Lavoinne, A., Hue, L., Proud, C. G., & Rider, M. H. (2002) · Current Biology · doi:10.1016/s0960-9822(02)01077-1 · Cited by 454
AMP kinase and malonyl-CoA: targets for therapy of the metabolic syndrome
Ruderman, N., & Prentki, M. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1344 · Cited by 451
Mutation analysis of 24 known cancer genes in the NCI-60 cell line set
Ikediobi, O. N., Davies, H., Bignell, G., Edkins, S., Stevens, C., O'Meara, S., Santarius, T., Avis, T., Barthorpe, S., Brackenbury, L., et al. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0433 · Cited by 440
AMPK, the metabolic syndrome and cancer
Luo, Z., Saha, A. K., Xiang, X., & Ruderman, N. B. (2005) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2004.12.011 · Cited by 426
Self-citationTAK1 activates AMPK‐dependent cytoprotective autophagy in TRAIL‐treated epithelial cells
Herrero‐Martín, G., Høyer‐Hansen, M., García‐García, C., Fumarola, C., Farkas, T., López‐Rivas, A., & Jäättelä, M. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.8 · Cited by 400
Important role of the LKB1-AMPK pathway in suppressing tumorigenesis in PTEN-deficient mice
Huang, X., Wullschleger, S., Shpiro, N., McGuire, V. A., Sakamoto, K., Woods, Y. L., Mcburnie, W., Fleming, S., & Alessi, D. R. (2008) · Biochemical Journal · doi:10.1042/bj20080557 · Cited by 396
Marsin, A.-S., Bouzin, C., Bertrand, L., & Hue, L. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205213200 · Cited by 379
Zheng, B., Jeong, J. H., Asara, J. M., Yuan, Y.-Y., Granter, S. R., Chin, L., & Cantley, L. C. (2009) · Molecular Cell · doi:10.1016/j.molcel.2008.12.026 · Cited by 359
Xie, M., Zhang, D., Dyck, J. R. B., Li, Y., Zhang, H., Morishima, M., Mann, D. L., Taffet, G. E., Baldini, A., Khoury, D. S., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0604708103 · Cited by 347
Imamura, K., Ogura, T., Kishimoto, A., Kaminishi, M., & Esumi, H. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5627 · Cited by 344
Horman, S., Vertommen, D., Heath, R., Neumann, D., Mouton, V., Woods, A., Schlattner, U., Wallimann, T., Carling, D., Hue, L., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m506850200 · Cited by 344
Rattan, R., Giri, S., Singh, A. K., & Singh, I. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m507443200 · Cited by 339
Adiponectin in relation to malignancies: a review of existing basic research and clinical evidence
Barb, D., Williams, C. J., Neuwirth, A. K., & Mantzoros, C. S. (2007) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/86.3.858s · Cited by 338
Roles of 5′-AMP-activated protein kinase (AMPK) in mammalian glucose homoeostasis
RUTTER, G. A., da SILVA XAVIER, G., & LECLERC, I. (2003) · Biochemical Journal · doi:10.1042/bj20030048 · Cited by 328
AMPK: Lessons from transgenic and knockout animals
Viollet, B. (2009) · Frontiers in bioscience · doi:10.2741/3229 · Cited by 314
Bensaad, K., & Vousden, K. H. (2007) · Trends in Cell Biology · doi:10.1016/j.tcb.2007.04.004 · Cited by 305
Effect of Acute Exercise on AMPK Signaling in Skeletal Muscle of Subjects with Type 2 Diabetes
Sriwijitkamol, A., Coletta, D. K., Wajcberg, E., Balbontin, G. B., Reyna, S. M., Barrientes, J., Eagan, P. A., Jenkinson, C. P., Cersosimo, E., DeFronzo, R. A., et al. (2007) · Diabetes · doi:10.2337/db06-1119 · Cited by 304
Fatty acid synthase: A metabolic oncogene in prostate cancer?
Baron, A., Migita, T., Tang, D., & Loda, M. (2004) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10708 · Cited by 292
Bandyopadhyay, G. K., Yu, J. G., Ofrecio, J., & Olefsky, J. M. (2006) · Diabetes · doi:10.2337/db06-0062 · Cited by 291
The regulation of AMP-activated protein kinase by upstream kinases
Carling, D., Sanders, M. J., & Woods, A. (2008) · International Journal of Obesity · doi:10.1038/ijo.2008.124 · Cited by 287
Okoshi, R., Ozaki, T., Yamamoto, H., Ando, K., Koida, N., Ono, S., Koda, T., Kamijo, T., Nakagawara, A., & Kizaki, H. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m705232200 · Cited by 277
Schrijver, E. D., Brusselmans, K., Heyns, W., Verhoeven, G., & Swinnen, J. V. (2003) · PubMed · Cited by 269
da SILVA XAVIER, G., LECLERC, I., VARADI, A., TSUBOI, T., MOULE, S. K., & RUTTER, G. A. (2003) · Biochemical Journal · doi:10.1042/bj20021812 · Cited by 257
Xiang, X., Saha, A. K., Wen, R., Ruderman, N. B., & Luo, Z. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.06.133 · Cited by 251
Self-citationHallstrom, T. C., Mori, S., & Nevins, J. R. (2008) · Cancer Cell · doi:10.1016/j.ccr.2007.11.031 · Cited by 249
Somatic LKB1 Mutations Promote Cervical Cancer Progression
Wingo, S. N., Gallardo, T. D., Akbay, E. A., Liang, M.-C., Contreras, C. M., Boren, T., Shimamura, T., Miller, D. S., Sharpless, N. E., Bardeesy, N., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005137 · Cited by 247
p53 and Metabolism: Inside the TIGAR
Green, D. R., & Chipuk, J. E. (2006) · Cell · doi:10.1016/j.cell.2006.06.032 · Cited by 239
AMP-Activated Protein Kinase: A Universal Regulator of Autophagy?
Høyer-Hansen, M., & Jäättelä, M. (2007) · Autophagy · doi:10.4161/auto.4240 · Cited by 229
LKB1 and AMPK Family Signaling: The Intimate Link Between Cell Polarity and Energy Metabolism
Jansen, M., ten Klooster, J. P., Offerhaus, G. J., & Clevers, H. (2009) · Physiological Reviews · doi:10.1152/physrev.00026.2008 · Cited by 221
mTOR and HIF-1α-mediated tumor metabolism in an LKB1 mouse model of Peutz-Jeghers syndrome
Shackelford, D. B., Vasquez, D. S., Corbeil, J., Wu, S., Leblanc, M., Wu, C.-L., Vera, D. R., & Shaw, R. J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0900465106 · Cited by 205
Phenotypes of the Tuberous Sclerosis Complex with a Revision of Diagnostic Criteria
GOMEZ, M. R. (1991) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1991.tb37742.x · Cited by 204
Metformin in Breast Cancer: Time for Action
Goodwin, P. J., Ligibel, J. A., & Stambolic, V. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.22.1630 · Cited by 200
Regulation of Transcription by AMP-activated Protein Kinase
Yang, W., Hong, Y. H., Shen, X.-Q., Frankowski, C., Camp, H. S., & Leff, T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c100316200 · Cited by 200
Effects of adiponectin on breast cancer cell growth and signaling
Grossmann, M. E., Nkhata, K. J., Mizuno, N. K., Ray, A., & Cleary, M. P. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604166 · Cited by 198
The Association Between Statins and Cancer Incidence in a Veterans Population
Farwell, W. R., Scranton, R. E., Lawler, E. V., Lew, R. A., Brophy, M. T., Fiore, L. D., & Gaziano, J. M. (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djm286 · Cited by 197
Thupari, J. N., Pinn, M. L., & Kuhajda, F. P. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5146 · Cited by 190
Adiponectin inhibits colorectal cancer cell growth through the AMPK/mTOR pathway
Nakajima (1992) · International Journal of Oncology · doi:10.3892/ijo_00000156 · Cited by 183
Bowker, S. L., Majumdar, S. R., Veugelers, P., & Johnson, J. A. (2006) · Diabetes Care · doi:10.2337/dc06-0997 · Cited by 175
Jiang, W., Zhu, Z., & Thompson, H. J. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6721 · Cited by 174
Histological evaluation of AMPK signalling in primary breast cancer
Hadad, S. M., Baker, L., Quinlan, P. R., Robertson, K. E., Bray, S. E., Thomson, G., Kellock, D., Jordan, L. B., Purdie, C. A., Hardie, D. G., et al. (2009) · BMC Cancer · doi:10.1186/1471-2407-9-307 · Cited by 172
Zhou, W., Han, W. F., Landree, L. E., Thupari, J. N., Pinn, M. L., Bililign, T., Kim, E. K., Vadlamudi, A., Medghalchi, S. M., Meskini, R. E., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3439 · Cited by 161
AMP‐activated protein kinase and cancer
Wang, W., & Guan, K. ‐. (2009) · Acta Physiologica · doi:10.1111/j.1748-1716.2009.01980.x · Cited by 160
Increased Tumor Growth in Mice with Diet-Induced Obesity: Impact of Ovarian Hormones
Yakar, S., Núñez, N. P., Pennisi, P. A., Brodt, P., Sun, H., Fallavollita, L., Zhao, H., Scavo, L. M., Novosyadlyy, R., Kurshan, N., et al. (2006) · Endocrinology · doi:10.1210/en.2006-0311 · Cited by 155
KSR2 Is an Essential Regulator of AMP Kinase, Energy Expenditure, and Insulin Sensitivity
Costanzo-Garvey, D. L., Pfluger, P. T., Dougherty, M. K., Stock, J. L., Boehm, M. B., Chaika, O. V., Fernandez, M. R., Fisher, K. W., Kortum, R. L., Hong, E., et al. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2009.09.010 · Cited by 150
The Molecular Scaffold KSR1 Regulates the Proliferative and Oncogenic Potential of Cells
Kortum, R. L., & Lewis, R. E. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.10.4407-4416.2004 · Cited by 149
KSR and CNK: two scaffolds regulating RAS-mediated RAF activation
Clapéron, A., & Therrien, M. (2007) · Oncogene · doi:10.1038/sj.onc.1210408 · Cited by 146
Carretero, J., Medina, P. P., Blanco, R., Smit, L., Tang, M., Roncador, G., Maestre, L., Conde, E., López‐Ríos, F., Clevers, H. C., et al. (2006) · Oncogene · doi:10.1038/sj.onc.1209951 · Cited by 144
Kim, K.-Y., Baek, A., Hwang, J.-E., Choi, Y. A., Jeong, J., Lee, M.-S., Cho, D. H., Lim, J., Kim, K. I., & Yang, Y. D. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2641 · Cited by 142
ARK5 Is a Tumor Invasion-Associated Factor Downstream of Akt Signaling
Suzuki, A., Lu, J., Kusakai, G.-I., Kishimoto, A., Ogura, T., & Esumi, H. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.8.3526-3535.2004 · Cited by 139
KSR2 Is a Calcineurin Substrate that Promotes ERK Cascade Activation in Response to Calcium Signals
Dougherty, M. K., Ritt, D. A., Zhou, M., Specht, S. I., Monson, D. M., Veenstra, T. D., & Morrison, D. K. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.06.001 · Cited by 131
Kraegen, E. W., Saha, A. K., Preston, E., Wilks, D. L., Hoy, A. J., Cooney, G. J., & Ruderman, N. B. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00316.2005 · Cited by 126
Therapy Insight: potential of statins for cancer chemoprevention and therapy
Katz, M. S. (2005) · Nature Clinical Practice Oncology · doi:10.1038/ncponc0097 · Cited by 123
LeRoith, D., Novosyadlyy, R., Gallagher, E. J., Lann, D. E., Vijayakumar, A., & Yakar, S. (2008) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-2008-1081488 · Cited by 120
Inactivation of AMPK alters gene expression and promotes growth of prostate cancer cells
Zhou, J., Huang, W., Tao, R., Ibaragi, S., Lan, F., Ido, Y., Wu, X., Alekseyev, Y. O., Lenburg, M. E., Hu, G.-F., et al. (2009) · Oncogene · doi:10.1038/onc.2009.63 · Cited by 118
Self-citationLoss of Lkb1 Provokes Highly Invasive Endometrial Adenocarcinomas
Contreras, C. M., Gurumurthy, S., Haynie, J. M., Shirley, L. J., Akbay, E. A., Wingo, S. N., Schorge, J. O., Broaddus, R. R., Wong, K., Bardeesy, N. M., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5014 · Cited by 116
Uncoupling of the LKB1-AMPKα Energy Sensor Pathway by Growth Factors and Oncogenic BRAFV600E
Esteve‐Puig, R., Canals, F., Colomé, N., Merlino, G. T., & Recio, J. A. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004771 · Cited by 114
5′-AMP-activated Protein Kinase Controls Insulin-containing Secretory Vesicle Dynamics
Tsuboi, T., Xavier, G. D. S., Leclerc, I., & Rutter, G. A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m307800200 · Cited by 107
Leo, V. D., Marca, A. L., Orvieto, R., & Morgante, G. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.4.6560 · Cited by 101
Insulin-Sensitizing Therapy Attenuates Type 2 Diabetes–Mediated Mammary Tumor Progression
Fierz, Y., Novosyadlyy, R., Vijayakumar, A., Yakar, S., & LeRoith, D. (2009) · Diabetes · doi:10.2337/db09-1291 · Cited by 93
IGF-1 phosphorylates AMPK-α subunit in ATM-dependent and LKB1-independent manner
Suzuki, A., Kusakai, G.-I., Kishimoto, A., Shimojo, Y., Ogura, T., Lavin, M. F., & Esumi, H. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.09.145 · Cited by 93
Accelerated Tumor Formation in a Fatless Mouse with Type 2 Diabetes and Inflammation
Núñez, N. P., Oh, W., Rozenberg, J. M., Perella, C., Anver, M. R., Barrett, J. C., Perkins, S. L., Berrigan, D. A., Moitra, J., Varticovski, L., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4102 · Cited by 88
Percik, R., & Stümvoll, M. (2009) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0029-1241870 · Cited by 85
Lkb1 Deficiency Causes Prostate Neoplasia in the Mouse
Pearson, H. B., McCarthy, A., Collins, C. M. P., Ashworth, A., & Clarke, A. R. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5169 · Cited by 82
LKB1 Deficiency Sensitizes Mice to Carcinogen-Induced Tumorigenesis
Gurumurthy, S., Hezel, A. F., Berger, J. H., Bosenberg, M., & Bardeesy, N. M. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-3225 · Cited by 82
AMP-Activated Protein Kinase Signaling Results in Cytoplasmic Sequestration of p27
Short, J. D., Houston, K. D., Dere, R., Cai, S.-L., Kim, J., Johnson, C. L., Broaddus, R. R., Shen, J., Miyamoto, S., Tamanoi, F., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5756 · Cited by 59
Conde, E., Suárez‐Gauthier, A., García-García, E., López‐Ríos, F., Encuentra, Á. L., García‐Luján, R., Morente, M. M., Sánchez-Verde, L., & Sánchez‐Céspedes, M. (2007) · Human Pathology · doi:10.1016/j.humpath.2007.01.022 · Cited by 59
Hwang, J.-T., Lee, M. Y., Jung, S., Lee, H., Kang, I., Kim, S. S., & Ha, J. (2004) · Carcinogenesis · doi:10.1093/carcin/bgh253 · Cited by 56
Lamontagne, J., Pépin, É., Peyot, M., Joly, E. C., Ruderman, N. B., Poitout, V., Madiraju, S. R. M., Nolan, C. J., & Prentki, M. (2009) · Endocrinology · doi:10.1210/en.2008-1557 · Cited by 55
Kim, C., Pennisi, P. A., Zhao, H., Yakar, S., Kaufman, J. B., Iganaki, K., Shiloach, J., Scherer, P. E., Quon, M. J., & LeRoith, D. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00319.2005 · Cited by 41
Lee, M. Y., Hwang, J., Yun, H., Kim, E. J., Kim, M., Kim, S. S., & Ha, J. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.03.021 · Cited by 29
Cited by
Salminen, A., Hyttinen, J. M. T., & Kaarniranta, K. (2011) · Journal of Molecular Medicine · doi:10.1007/s00109-011-0748-0 · Cited by 866
Metabolic control of cell death
Green, D. R., Galluzzi, L., & Kroemer, G. (2014) · Science · doi:10.1126/science.1250256 · Cited by 647
Lipids and cancer: Emerging roles in pathogenesis, diagnosis and therapeutic intervention
Butler, L. M., Perone, Y., Dehairs, J., Lupien, L. E., de Laat, V., Talebi, A., Loda, M., Kinlaw, W. B., & Swinnen, J. V. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.07.013 · Cited by 589
NAD+ metabolism, stemness, the immune response, and cancer
Navas, L. E., & Carnero, A. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00354-w · Cited by 517
SnRK2 Protein Kinases—Key Regulators of Plant Response to Abiotic Stresses
Kulik, A., Wawer, I., Krzywińska, E., Bucholc, M., & Dobrowolska, G. (2011) · OMICS: A Journal of Integrative Biology · doi:10.1089/omi.2011.0091 · Cited by 498
Metadata
- Authors
- Luo, Z., Zang, M., & Guo, W.
- Venue
- Future Oncology
- Publisher
- Informa UK Limited
- Published
- 2010-03-11
- Volume
- 6
- Issue
- 3
- Pages
- 457-470
- ISSN
- 1479-6694 (ISSN-L)
- 1744-8301
- OpenAlex
- W2155598285
- Cited by
- 383
- References
- 124
- FWCI
- 11.11
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.